Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Standing Risk Factors

  • Going Concern (unchanged) — The auditor raised substantial doubt about the company's ability to continue as a going concern, tied to recurring losses, negative cash flows, and liquidity needs.
NASDAQ: TPST Tempest Therapeutics, Inc. 424B3

Tempest registers up to 8.9M shares for resale by Lincoln Park under $50M equity purchase agreement

Filed September 1, 2026 · ~1 min read

Key Changes

  • high

    The prospectus registers up to 8,910,579 shares for resale by Lincoln Park Capital Fund, LLC, the selling stockholder.

    The Offering verify on EDGAR →
  • high

    Tempest will not receive any proceeds from Lincoln Park's resale of these shares.

    The Offering verify on EDGAR →
  • high

    Under the purchase agreement, Tempest may receive up to $25 million initially, with an automatic increase to $50 million total after the initial amount is fully drawn.

    The Offering verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify